WCN26-5512 Mortality comparison between the COVID-19 Omicron variant and influenza among kidney transplant recipients: a nationwide population-based retrospective cohort study
Kidney International Reports 2026 Open access
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT
Free to try with your Science Catalogs account.
Abstract
Introduction: Although the SARS-CoV-2 Omicron variant demonstrates lower mortality than previous variants in the general population, its mortality risk in immunocompromised kidney transplant recipients (KTRs)remains concerning.The present study compared Omicronrelated mortality with that of seasonal influenza in KTRs.Methods: Using the National Database of Health Insurance Claims of Japan, we conducted a retrospective cohort study of KTRs diagnosed with COVID-19 during the Omicron period (January 2022-March 2023) or influenza (September 2017-March 2023).The primary outcome was 30-day all-cause mortality.Inverse probability of treatment weighting (IPTW) based on propensity scores was employed to adjust for confounding factors.Subgroup analyses were performed stratified by age groups (20-49, 50-59, 60-69, and $70 years).Results: We identified 6,488 COVID-19 and 5,347 influenza cases.After IPTW, the 30-day mortality rates were 1.2% for COVID-19 and 0.2% for influenza (hazard ratio [HR] 4.07 [95% CI 2.18, 7.59]).In subgroup analyses stratified by age, adjusted HRs were as follows: 20-49 years, not estimable due to sparse events; 50-59 years, 2.06 (0.57, 7.48); 60-69 years, 6.52 (1.89, 22.48); and $70 years, 3.93 (1.62, 9.54).The adjusted absolute risk differences (excess deaths per 1,000 patients) were 0.1, 3.4, 17.3, and 35.0, respectively.Conclusion: In this nationwide study, COVID-19 Omicron variant was associated with significantly higher mortality than influenza in KTRs.Age-stratified analyses demonstrated significantly elevated mortality in patients aged $60 years; however, further investigation is warranted in younger age groups given the limited number of events. I have potential conflict of interest to disclose.No conflict of interest.This study was supported by the Study Group on Diffuse Lung Disease and Scientific Research/Research on Intractable Diseases of the Japan Ministry of Health, Labor and Welfare (JPMH23FC1030). I used generative AI and AI-assisted technologies in the writing process.During the preparation of this work the authors used Claude/Anthropic in order to enhance readability and provide proofreading assistance for this abstract.After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.
Fields of Study & Subjects
COVID-19 Clinical Research Studies
SARS-CoV-2 and COVID-19 Research
COVID-19 epidemiological studies
Publication details
- Journal / source
- Kidney International Reports
- Volume
- 11
- Issue
- 4
- Pages
- 105500–105500
- Publication date
- 25 March 2026
- Language
- EN